by Zhang Nannan,Chinese Academy of SciencesDiagram of curcumin maintaining microglial homeostasis. Credit: IGDBA new studypublishedinAdvanced Sciencehas revealed how curc
by Zhang Nannan,Chinese Academy of SciencesDiagram of curcumin maintaining microglial homeostasis. Credit: IGDBA new studypublishedinAdvanced Sciencehas revealed how curc
by Julie Langelier,Gladstone InstitutesPET scan of a human brain with Alzheimer's disease. Credit: public domainIt has long been known that patients with Alzheimer's disease have abnorma
by Julie Langelier,Gladstone InstitutesPET scan of a human brain with Alzheimer's disease. Credit: public domainIt has long been known that patients with Alzheimer's disease have abnorma
by VIB (the Flanders Institute for Biotechnology)Credit: Opabinia regalis, CC BY-SA 4.0A research team led by Wim Annaert (VIB-KU Leuven) uncovered the early assembly of gamma-secretase, a protei
by VIB (the Flanders Institute for Biotechnology)Credit: Opabinia regalis, CC BY-SA 4.0A research team led by Wim Annaert (VIB-KU Leuven) uncovered the early assembly of gamma-secretase, a protei
byMass General BrighamCredit: Unsplash/CC0 Public DomainDespite improvements in CPR and rates of getting patients to the hospital, only about 10% of people ultimately survive after out-of-hospit
byMass General BrighamCredit: Unsplash/CC0 Public DomainDespite improvements in CPR and rates of getting patients to the hospital, only about 10% of people ultimately survive after out-of-hospit
byMary Ann Liebert, IncCredit: Wikimedia CommonsWith recent advances in neuroimaging, moving from qualitative to quantitative outputs, an understanding is needed of what normal data look like to
byMary Ann Liebert, IncCredit: Wikimedia CommonsWith recent advances in neuroimaging, moving from qualitative to quantitative outputs, an understanding is needed of what normal data look like to
by Christian Holscher,The ConversationCredit: AI-generated imageJohnson and Johnsonrecently announcedthat it was halting a clinical trial for a new Alzheimer's drug after safety
by Christian Holscher,The ConversationCredit: AI-generated imageJohnson and Johnsonrecently announcedthat it was halting a clinical trial for a new Alzheimer's drug after safety